Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolande A Land

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Human Reproduction (Oxford, England)|July 11, 2006
How should we report on perinatal outcome?Jolande A Land
The Lancet. Global Health|August 13, 2019
Prevalence of Chlamydia trachomatis infections in the Middle East and north Africa, what next?Jolande A Land, Elena Ambrosino
Human Reproduction Update|August 30, 2011
Effects of advanced selection methods on sperm quality and ART outcome: a systematic reviewTamer M Said, Jolande A Land
Human Reproduction (Oxford, England)|March 16, 2004
What is the most relevant standard of success in assisted reproduction? Defining outcome in ART: a Gordian knot of safety, efficacy and qualityJolande A Land, Johannes L H Evers
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 11, 2002
Chlamydia infection and subfertilityJolande A Land, Johannes L H Evers
Fertility and Sterility|May 10, 2011
The long-term outcome of 946 consecutive couples visiting a fertility clinic in 2001-2003Janneke Donckers, Johannes L H Evers, Jolande A Land
Obstetrical & Gynecological Survey|April 19, 2008
Fertility and impact of pregnancies on the mother and child in classic galactosemiaCynthia S Gubbels, Jolande A Land, M Estela Rubio-Gozalbo
Seminars in Reproductive Medicine|June 14, 2003
Evidence-based medicine for diagnostic questionsJohannes L H Evers, Jolande A Land, Ben W Mol
Human Reproduction (Oxford, England)|March 1, 2002
Chlamydia trachomatis in subfertile women undergoing uterine instrumentation. Screen or treat?Jolande A Land, Anna P Gijsen, Johannes L H Evers, et al.
Pathogens and Disease|September 1, 2017
Performance of the multitarget Mikrogen Chlamydia trachomatis IgG ELISA in the prediction of tubal factor infertility (TFI) in subfertile women: comparison with the Medac MOMP IgG ELISA plusEleanne F van Ess, Sander Ouburg, Joke Spaargaren, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Human Reproduction (Oxford, England)|July 11, 2006
How should we report on perinatal outcome?Jolande A Land
The Lancet. Global Health|August 13, 2019
Prevalence of Chlamydia trachomatis infections in the Middle East and north Africa, what next?Jolande A Land, Elena Ambrosino
Human Reproduction Update|August 30, 2011
Effects of advanced selection methods on sperm quality and ART outcome: a systematic reviewTamer M Said, Jolande A Land
Human Reproduction (Oxford, England)|March 16, 2004
What is the most relevant standard of success in assisted reproduction? Defining outcome in ART: a Gordian knot of safety, efficacy and qualityJolande A Land, Johannes L H Evers
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 11, 2002
Chlamydia infection and subfertilityJolande A Land, Johannes L H Evers
Fertility and Sterility|May 10, 2011
The long-term outcome of 946 consecutive couples visiting a fertility clinic in 2001-2003Janneke Donckers, Johannes L H Evers, Jolande A Land
Obstetrical & Gynecological Survey|April 19, 2008
Fertility and impact of pregnancies on the mother and child in classic galactosemiaCynthia S Gubbels, Jolande A Land, M Estela Rubio-Gozalbo
Seminars in Reproductive Medicine|June 14, 2003
Evidence-based medicine for diagnostic questionsJohannes L H Evers, Jolande A Land, Ben W Mol
Human Reproduction (Oxford, England)|March 1, 2002
Chlamydia trachomatis in subfertile women undergoing uterine instrumentation. Screen or treat?Jolande A Land, Anna P Gijsen, Johannes L H Evers, et al.
Pathogens and Disease|September 1, 2017
Performance of the multitarget Mikrogen Chlamydia trachomatis IgG ELISA in the prediction of tubal factor infertility (TFI) in subfertile women: comparison with the Medac MOMP IgG ELISA plusEleanne F van Ess, Sander Ouburg, Joke Spaargaren, et al.
Pageof 5